VGLL2 anticorps (N-Term)
Aperçu rapide pour VGLL2 anticorps (N-Term) (ABIN955512)
Antigène
Voir toutes VGLL2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 52-81, N-Term
-
Specificité
- This antibody detects VGLL2 / VITO1 (N-term).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse
-
Purification
- Protein A column followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 52-81 amino acids from the N-terminal region of human VGLL2
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- VGLL2 (Vestigial Like 2 (VGLL2))
-
Autre désignation
- VGLL2 / VITO1
-
Sujet
- May act as a specific coactivator for the mammalian TEFs. May play a role in the development of skeletal muscles.Synonyms: Transcription cofactor vestigial-like protein 2, Vgl-2
-
ID gène
- 245806
-
NCBI Accession
- NP_703154
Antigène
-